A novel presbyopia drop improves near vision using pupillary constriction to create a pinhole effect, while allowing good distance vision.

In a phase 3 trial, Tenpoint Therapeutics’ eye drop—a combination of carbachol and brimonidine—improved vision for patients ...

Tenpoint Therapeutics, Inc., a global, clinical-stage biotech company developing groundbreaking treatments to rejuvenate vision in the aging eye, today reported positive topline results from BRIO-II, ...

Sight Sciences (SGHT) announced the publication of a landmark 36-month analysis evaluating the long-term effectiveness of the OMNI Surgical ...